tiprankstipranks
RegenXBio (RGNX)
NASDAQ:RGNX

RegenXBio (RGNX) Technical Analysis

488 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
2Neutral
14Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
RegenXBio’s (RGNX) Moving Averages Convergence Divergence (MACD) indicator is -0.98, suggesting RegenXBio is a Buy.
RegenXBio’s (RGNX) 20-Day exponential moving average is 14.01, while RegenXBio’s (RGNX) share price is $12.21, making it a Sell.
RegenXBio’s (RGNX) 50-Day exponential moving average is 15.52, while RegenXBio’s (RGNX) share price is $12.21, making it a Sell.

RegenXBio (RGNX) Pivot Points

Jun 19, 2024, 12:06 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
11.61
11.98
12.20
12.57
12.79
13.16
13.38
Fibonacci
11.98
12.21
12.35
12.57
12.80
12.94
13.16
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

RegenXBio (RGNX) Moving Averages

Jun 19, 2024, 12:06 AM
Period
Simple
Exponential
MA5
12.77Sell
12.62Sell
MA10
13.42Sell
13.23Sell
MA20
14.17Sell
14.01Sell
MA50
15.68Sell
15.52Sell
MA100
17.28Sell
16.58Sell
MA200
17.24Sell
16.98Sell
RegenXBio’s (RGNX) 10-Day exponential moving average is 13.23, while RegenXBio’s (RGNX) share price is $12.21, making it a Sell.
RegenXBio’s (RGNX) 100-Day exponential moving average is 16.58, while RegenXBio’s (RGNX) share price is $12.21, making it a Sell.
RegenXBio’s (RGNX) stock price is $12.21 and RegenXBio’s (RGNX) 50-day simple moving average is 15.68, creating a Sell signal.
RegenXBio’s (RGNX) stock price is $12.21 and RegenXBio’s (RGNX) 100-day simple moving average is 17.28, creating a Sell signal.
RegenXBio’s (RGNX) stock price is $12.21 and RegenXBio’s (RGNX) 200-day simple moving average is 17.24, creating a Sell signal.

RegenXBio (RGNX) Technical Indicators

Jun 19, 2024, 12:06 AM
Name
Value
Implied Action
RSI (14)
21.01
Buy
STOCH (9,6)
7.99
Buy
STOCHRSI (14)
6.77
Buy
MACD (12,26)
-0.98
Buy
ADX (14)
36.26
Neutral
Williams %R
-97.64
Buy
CCI (14)
-205.55
Buy
ATR (14)
0.80
-
Ultimate Oscillator
33.92
Neutral
ROC
-22.19
Sell
RegenXBio’s (RGNX) Relative Strength Index (RSI) is 21.01, creating a Buy signal.
RegenXBio’s (RGNX) Trend Strength Indicator (ADX) is 36.26, creating a Neutral signal.
RegenXBio’s (RGNX) Commodity Channel Index (CCI) is -205.55, creating a Buy signal.
RegenXBio’s (RGNX) Price Rate of Change (ROC) is -22.19, creating a Sell signal.

FAQ

Is RGNX a Buy, Hold, or Sell?
Based on RGNX’s technical indicators, RGNX is a Sell.
    What is RGNX’s RSI (14)?
    RGNX’s RSI (14) is 21.01, which suggests RGNX is a Buy.
      What is RGNX’s MACD?
      RGNX’s MACD is -0.98, which suggests RGNX is a Buy.
        What is RGNX’s 5-day moving average?
        RGNX’s 5-day moving average is 12.77, which suggests RGNX is a Sell.
          What is RGNX’s 20-day moving average?
          RGNX 20-day moving average is 14.17, which suggests RGNX is a Sell.
            What is RGNX’s 50-day moving average?
            RGNX’s 50-day moving average is 15.68, which suggests RGNX is a Sell.
              What is RGNX’s 200-day moving average?
              RGNX’s 200-day moving average is 17.24, which suggests RGNX is a Sell.
                What is RGNX’s Williams % R (14)?
                RGNX’s Williams % R (14) is -97.64, which suggests RGNX is a Buy.
                  What is RGNX’s CCI (14)?
                  RGNX’s CCI (14) is -205.55, which suggests RGNX is a Buy.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis